Gilead Sciences Inc Stock
Price
Target price
€102.58
€102.58
-2.920%
-3.06
-2.920%
€118.99
12.12.25 / Tradegate
WKN: 885823 / Symbol: GILD / Name: Gilead Sciences / Stock / Biotechnology & Medical Research / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Gilead Sciences Inc Stock
We can see a decrease in the price for Gilead Sciences Inc. Compared to yesterday it has lost -€3.060 (-2.920%).
With 37 Buy predictions and not a single Sell prediction Gilead Sciences Inc is an absolute favorite of our community.
As a result the target price of 118 € shows a slightly positive potential of 15.03% compared to the current price of 102.58 € for Gilead Sciences Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Gilead Sciences Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Gilead Sciences Inc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Gilead Sciences Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | -2.920% | -1.479% | -3.699% | 16.212% | 14.206% | 22.046% | 104.546% |
| Regeneron Pharmaceuticals Inc. | -1.700% | 2.399% | 7.342% | -10.766% | -6.623% | -10.399% | 59.535% |
| Exact Sciences | 0.300% | -0.369% | 46.584% | 44.720% | 59.011% | 100.533% | -19.111% |
| Incyte Corp. | -1.780% | -7.654% | -12.952% | 20.154% | 23.737% | 4.030% | 21.265% |
Comments
Gilead Sciences (NASDAQ:GILD) had its price target raised by analysts at Morgan Stanley from $147.00 to $151.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences (NASDAQ:GILD) had its price target raised by analysts at Wells Fargo & Company from $145.00 to $150.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences (NASDAQ:GILD) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $140.00 price target on the stock.
Show more
Ratings data for GILD provided by MarketBeat
